29 phenotypes from 4 alleles in 4 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Fcmrtm1.2Khl/Fcmrtm1.2Khl involves: C57BL/6	abnormal granulocyte physiology	J:194323
	decreased B cell number	J:174871
	decreased circulating alanine transaminase level	J:174871
	decreased susceptibility to injury	J:174871
	decreased susceptibility to xenobiotic induced morbidity/mortality	J:174871
	normal immune system phenotype	J:174871
	increased T cell apoptosis	J:174871
Fcmrtm1b(KOMP)Wtsi/Fcmrtm1b(KOMP)Wtsi C57BL/6N-Fcmrtm1b(KOMP)Wtsi/Ucd	decreased prepulse inhibition	J:211773
	enlarged adrenal glands	J:211773
Fcmrtm1Mak/Fcmrtm1Mak B6.129S2-Fcmrtm1Mak	abnormal cytokine secretion	J:194323
	abnormal granulocyte physiology	J:194323
	decreased interleukin-6 secretion	J:194323
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:194323
	decreased tumor necrosis factor secretion	J:194323
	normal hematopoietic system phenotype	J:194323
	impaired granulocyte bactericidal activity	J:194323
	increased susceptibility to bacterial infection	J:194323
	increased susceptibility to bacterial infection induced morbidity/mortality	J:194323
Fcmrtm1Ohno/Fcmrtm1Ohno B6.129-Fcmrtm1Ohno	abnormal B cell morphology	J:190117
	abnormal immunoglobulin level	J:190117
	abnormal response to infection	J:190117
	decreased IgG1 level	J:190117
	decreased IgM level	J:190117
	decreased marginal zone B cell number	J:190117
	increased anti-chromatin antibody level	J:190117
	increased anti-double stranded DNA antibody level	J:190117
	increased B-1 B cell number	J:190117
	increased IgG3 level	J:190117
	increased IgM level	J:190117
	increased T cell number	J:190117